Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:49 UTC |
---|
HMDB ID | HMDB0015020 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clomifene |
---|
Description | Clomifene is only found in individuals that have used or taken this drug. It is a triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue. [PubChem]Clomifene has both estrogenic and anti-estrogenic properties, but its precise mechanism of action has not been determined. Clomifene appears to stumulate the release of gonadotropins, follicle-stimulating hormone (FSH), and leuteinizing hormone (LH), which leads to the development and maturation of ovarian follicle, ovulation, and subsequent development and function of the coprus luteum, thus resulting in pregnancy. Gonadotropin release may result from direct stimulation of the hypothalamic-pituitary axis or from a decreased inhibitory influence of estrogens on the hypothalamic-pituitary axis by competing with the endogenous estrogens of the uterus, pituitary, or hypothalamus. Clomifene has no apparent progestational, androgenic, or antrandrogenic effects and does not appear to interfere with pituitary-adrenal or pituitary-thyroid function. |
---|
Structure | CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
2-(4-(2-Chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine | ChEBI | 2-(p-(2-Chloro-1,2-diphenylvinyl)phenoxy)triethylamine | ChEBI | 2-(p-(beta-Chloro-alpha-phenylstyryl)phenoxy)triethylamine | ChEBI | Clomifeno | ChEBI | Clomifenum | ChEBI | 2-(p-(b-Chloro-a-phenylstyryl)phenoxy)triethylamine | Generator | 2-(p-(Β-chloro-α-phenylstyryl)phenoxy)triethylamine | Generator | Chlomaphene | HMDB | Chloramifene | HMDB | Chloramiphene | HMDB | Cisclomiphene | HMDB | Clomifene citrate | HMDB | Clomiphene | HMDB | Clomiphene citrate | HMDB | Clomiphene citrate (Z,e) | HMDB | Racemic clomiphene citrate | HMDB | Zuclomiphene citrate | HMDB | Clostilbegit | MeSH, HMDB | Gravosan | MeSH, HMDB | Klostilbegit | MeSH, HMDB | Serophene | MeSH, HMDB | Clomid | MeSH, HMDB | Clomifen | MeSH, HMDB | Citrate, clomiphene | MeSH, HMDB | Clomide | MeSH, HMDB | Dyneric | MeSH, HMDB | Clomiphene hydrochloride | MeSH, HMDB | Hydrochloride, clomiphene | MeSH, HMDB | Clomifene | ChEBI |
|
---|
Chemical Formula | C26H28ClNO |
---|
Average Molecular Weight | 405.96 |
---|
Monoisotopic Molecular Weight | 405.18594223 |
---|
IUPAC Name | {2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]ethyl}diethylamine |
---|
Traditional Name | pioner |
---|
CAS Registry Number | 911-45-5 |
---|
SMILES | CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3 |
---|
InChI Key | GKIRPKYJQBWNGO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Stilbenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Stilbenes |
---|
Alternative Parents | |
---|
Substituents | - Stilbene
- Diphenylmethane
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Monocyclic benzene moiety
- Benzenoid
- Tertiary amine
- Tertiary aliphatic amine
- Ether
- Chloroalkene
- Haloalkene
- Vinyl halide
- Vinyl chloride
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Amine
- Organic oxygen compound
- Organopnictogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00041 g/L | Not Available | LogP | 7.2 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clomifene GC-MS (Non-derivatized) - 70eV, Positive | splash10-052r-9012000000-45df4fe468787edb6d89 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clomifene GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clomifene GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomifene LC-ESI-qTof , Positive-QTOF | splash10-0a4i-0000900000-6e563271338e3449b9f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Clomifene , positive-QTOF | splash10-0a4i-0000900000-6e563271338e3449b9f0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 10V, Positive-QTOF | splash10-0a4i-1312900000-ca9aa2374db80c007b5f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 20V, Positive-QTOF | splash10-0udr-4933200000-164fa87cdbe23cc72977 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 40V, Positive-QTOF | splash10-0fi9-9451000000-5927a010de880212b24f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 10V, Negative-QTOF | splash10-0udi-1323900000-270e95f39bc9c23eae50 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 20V, Negative-QTOF | splash10-0pb9-4129400000-86f55d0b88e5983df5a4 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 40V, Negative-QTOF | splash10-05i0-9454000000-848ee095f1842299cd00 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 10V, Positive-QTOF | splash10-0a4i-0000900000-ff68a542dc5bb5928f03 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 20V, Positive-QTOF | splash10-0pb9-0801900000-ebdadab4e693385de318 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 40V, Positive-QTOF | splash10-0uk9-9710000000-e2c0a936a58120fde734 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 10V, Negative-QTOF | splash10-0udi-1000900000-551503881b71c4f9f47c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 20V, Negative-QTOF | splash10-0ue9-7035900000-c45916b720c3b1c8bb5d | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clomifene 40V, Negative-QTOF | splash10-0a4i-0019000000-2f31a2afd1fc50c9b823 | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
General References | - Hughes E, Brown J, Collins JJ, Vanderkerchove P: Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000057. doi: 10.1002/14651858.CD000057.pub2. [PubMed:20091498 ]
- Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E: Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002249. doi: 10.1002/14651858.CD002249.pub4. [PubMed:19821295 ]
- Authors unspecified: Use of clomiphene citrate in women. Fertil Steril. 2006 Nov;86(5 Suppl 1):S187-93. [PubMed:17055820 ]
- Homburg R: Oral agents for ovulation induction--clomiphene citrate versus aromatase inhibitors. Hum Fertil (Camb). 2008 Mar;11(1):17-22. doi: 10.1080/14647270701689670. [PubMed:18320435 ]
- Homburg R: Clomiphene citrate--end of an era? A mini-review. Hum Reprod. 2005 Aug;20(8):2043-51. Epub 2005 May 5. [PubMed:15878925 ]
- Purvin VA: Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol. 1995 Apr;113(4):482-4. [PubMed:7710399 ]
- Fritz MA, Holmes RT, Keenan EJ: Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. Am J Obstet Gynecol. 1991 Jul;165(1):177-85. [PubMed:1906682 ]
- Hayon T, Atlas L, Levy E, Dvilansky A, Shpilberg O, Nathan I: Multifactorial activities of nonsteroidal antiestrogens against leukemia. Cancer Detect Prev. 2003;27(5):389-96. [PubMed:14585326 ]
|
---|